Hussman Strategic Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.32M | Buy |
105,000
+21,000
| +25% | +$664K | 0.76% | 34 |
|
|
2025
Q1 | $2.79M | Hold |
84,000
| – | – | 0.68% | 36 |
|
|
2024
Q4 | $2.89M | Buy |
84,000
+21,000
| +33% | +$723K | 0.85% | 25 |
|
|
2024
Q3 | $2.52M | Buy |
63,000
+42,000
| +200% | +$1.68M | 0.62% | 54 |
|
|
2024
Q2 | $634K | Hold |
21,000
| – | – | 0.17% | 178 |
|
|
2024
Q1 | $705K | Hold |
21,000
| – | – | 0.16% | 166 |
|
|
2023
Q4 | $678K | Sell |
21,000
-10,000
| -32% | -$323K | 0.15% | 175 |
|
|
2023
Q3 | $1.02M | Hold |
31,000
| – | – | 0.19% | 195 |
|
|
2023
Q2 | $1.09M | Hold |
31,000
| – | – | 0.2% | 202 |
|
|
2023
Q1 | $1.01M | Buy |
+31,000
| New | +$1.01M | 0.16% | 214 |
|